Accurate Diagnosis Of Breast Cancer Research Articles

AI-Driven Elastography Image Analysis for Accurate Breast Cancer Diagnosis

AI-Driven Elastography Image Analysis for Accurate Breast Cancer Diagnosis

Breast Cancer Diagnosis Utilizing Artificial Neural Network (ANN) Algorithm for Integrating Multi-Omics Data and Clinical Features

Breast cancer is one of the most common diseases affecting women worldwide, with a significant impact on patient's health and quality of life. Despite advances in medical technology and research, breast cancer diagnosis remains a challenge due to its complexity involving various biological and clinical factors. Several previous studies have focused on detecting this disease with optimal accuracy, but the selection of appropriate algorithms and methods is key to achieving this goal. This study aims to improve the accuracy of breast cancer diagnosis by using the ANN algorithm and data balancing method, SMOTE. This research uses Multi-Omic data and Clinical Features obtained in general from Kaggle. The research process is carried out in several stages, namely Data Collection, Preprocessing, Oversampling, Modeling, and Evaluation. This research successfully obtained an increase in accuracy, which was able to achieve an accuracy of 99.30%. This research shows that early detection of breast cancer with ANN algorithm and data balancing using SMOTE can improve accuracy performance in early detection of breast cancer. Given the use of data in this study is not too large, it is recommended for further research to use a larger dataset to validate the strength of the model that has been built on more varied data.

Age‑integrated breast imaging reporting and data system assessment model to improve the accuracy of breast cancer diagnosis.

Early diagnosis is an effective strategy for decreasing breast cancer mortality. Ultrasonography is one of the most predominant imaging modalities for breast cancer owing to its convenience and non-invasiveness. The present study aimed to develop a model that integrates age with Breast Imaging Reporting and Data System (BI-RADS) lexicon to improve diagnostic accuracy of ultrasonography in breast cancer. This retrospective study comprised two cohorts: A training cohort with 975 female patients from Renmin Hospital of Wuhan University (Wuhan, China) and a validation cohort with 500 female patients from Maternal and Child Health Hospital of Hubei Province (Wuhan, China). Logistic regression was used to construct a model combining BI-RADS score with age and to determine the age-based prevalence of breast cancer to predict a cut-off age. The model that integrated age with BI-RADS scores demonstrated the best performance compared with models based solely on age or BI-RADS scores, with an area under the curve (AUC) of 0.872 (95% CI: 0.850-0.894, P<0.001). Furthermore, among participants aged <30 years, the prevalence of breast cancer was lower than the lower limit of the reference range (2%) for BI-RADS subcategory 4A lesions but within the reference range for BI-RADS category 3 lesions, as indicated by linear regression analysis. Therefore, it is recommended that management for this subset of participants are categorized as BI-RADS category 3, meaning that biopsies typically indicated could be replaced with short-term follow-up. In conclusion, the integrated assessment model based on age and BI-RADS may enhance accuracy of ultrasonography in diagnosing breast lesions and young patients with BI-RADS subcategory 4A lesions may be exempted from biopsy.

Advancing Breast Cancer Diagnosis: The Impact of Elastography Integration Into Breast Imaging Reporting and Data System (BIRADS) Categorization.

This study evaluates the impact of integrating elastography into the Breast Imaging Reporting and Data System (BIRADS) categorization on breast cancer diagnostics in an African population. It explores the association and agreement between traditional BIRADS and those modified by elastography, as well as between quantitative and qualitative elastography methods. A total of 200 participants who underwent breast imaging as part of their diagnostic evaluation for breast lesions were included in the study. Participant characteristics, including age distribution and indicators for breast cancer diagnoses, were analyzed. Brightness mode (B-mode) findings without elastography were assessed using the BIRADS classification. Elastography was integrated into the BIRADS categorization to evaluate its impact on breast cancer diagnostics.The association and agreement between BIRADS with and without elastography were analyzed. Participants predominantly aged 40-49 showed significant staging differences with the integration of elastography. Traditional B-mode staging identified 29 (49%) of participants in BIRADS stage IV and 14 (23%) in stage V, whereas elastography adjusted these figures significantly, enhancing diagnostic refinement. There was a fair agreement between BIRADS with and without elastography (kappa = 0.322), while a substantial agreement was found between quantitative and qualitative elastography (kappa = 0.674). The results of the study provide evidence that the integration of elastography into BIRADS categorization can significantly improve the accuracy of breast cancer diagnosis in African women. Elastography enhanced lesion characterization, supporting more personalized and precise clinical management. Continued research is needed to fully integrate elastography into routine diagnostic workflows and understand its broader clinical implications in Africa.

Novel feature selection method for accurate breast cancer classification using Correlation coefficient and Modified GWO Algorithm

Breast cancer is perceived as the most common cause of mortality among women globally. Early detection of this disease is critical to reduce significantly the possibility of death. Machine learning techniques have been proved to be efficient and very successful for an accurate breast cancer diagnosis. In this paper, an efficient hybrid Feature Selection (FS) method named a Correlation technique-Modified Grey Wolf Optimizer (CMGWO) was proposed for accurate breast cancer classification based on dimensionality reduction. The suggested technique is based on two stages: the feature selection step and the classification step. Feature selection is the process of picking the most significant characteristics from a dataset. This stage is crucial in machine learning. Firstly, we focus on the filter method by using a Correlation technique for dimensionality reduction. This technique is intended to eliminate and reduce the number of features by selecting one feature from the other correlated features. Secondly, we use the Modified Grey Wolf Optimization algorithm (MGWO) to locate and determine the most significant features from uncorrelated features. After that, we use multiple classifiers to classify breast cancer disease based on the selected features. The Wisconsin Diagnostic Breast Cancer (WDBC) database was used to prove the performance of our proposed work. The experimental results show that the combination of the correlation method and MGWO for feature selection increases the accuracy rate of classification with a minimum number of features. The performances of different machine learning algorithms were evaluated, including Random Forest classifier (RF), Support Vector Machine (SVM) Classifier, and Naïve Bayes (NB) Classifier for the classification step. The suggested technique proves to be the best approach and reliable one among all studied approaches since it increases classification accuracy to 99.12\% obtained by CMGWO using Random Forest classifier and demonstrates its significance in detecting breast cancer.

Enhancing breast cancer diagnosis accuracy through genetic algorithm-optimized multilayer perceptron

Enhancing breast cancer diagnosis accuracy through genetic algorithm-optimized multilayer perceptron

Efficient Machine Learning and Deep Learning Techniques for Detection of Breast Cancer Tumor

The detection of cancer tumors is an essential component that has important consequences for the speedy involvement of medical professionals and the enhancement of patient outcomes. This review paper presents a complete study of the current body of research and methodology, as well as an in-depth assessment of the use of machine learning (ML) and deep learning (DL) in the detection of cancer tumors. In addition, the article gives a full analysis of the approaches involved. Machine learning and deep learning, which effectively handle ambiguity in the identification of malignant tumors, provide an alternative method for dealing with the complexity of brain tissue. This method is offered by a combination of machine learning and deep learning. The first part of the review draws attention to the significance of making an accurate diagnosis of breast cancer, highlights the limits of traditional diagnostic methods, and investigates the cutting-edge area of medical imaging technology. After that, it investigates the fundamentals of ML and DL and how they might be used to deal with the challenges that are inherent in the interpretation of complicated imaging data. In addition, the paper explores the ways in which models enhance the processes of feature extraction, picture segmentation, and classification in breast tumor detection systems.

Abstract PO2-13-12: Serum Thioredoxin 1 Enhances Breast Cancer Detection in Mammography and Breast Ultrasound, Including Dense Breasts

Abstract Background: Breast cancer (BC), when detected in its early stages, generally carries a more favorable prognosis than other types of cancer. Currently, the screening and early detection of breast cancer rely predominantly on image-oriented diagnostic methods. However, these methods inherently fall short in capturing the dynamic nature of cancer cells. Mammography has known limitations in clinical sensitivity, particularly in cases with high breast density. While breast ultrasound can mitigate some of these limitations, there remain unmet needs in this field. Previously, we reported the promising clinical performance (Sensitivity: 96.43%, Specificity: 97.32%) of serum thioredoxin 1 (Trx1) as a potential novel means for detecting breast cancer. In this study, we aim to evaluate the extent to which serum Trx1 can enhance the accuracy of breast cancer diagnosis, including in dense breasts, within the imaging-based diagnostic system powered by mammography and ultrasonography. Methods: We have generated monoclonal antibodies against Trx1 and developed an ELISA kit (DxMe® BC Kit, E&amp;S Healthcare, Korea) that quantifies Trx1 in serum. A total of 308 biopsy-confirmed breast cancer patients, who had undergone mammography prior to their final diagnosis, were recruited. The clinical information of these 308 patients was retrospectively examined and collected. The data from 254 individuals, who also had results from breast ultrasound, and 261 individuals, who had records of breast density, were analyzed collectively. Freshly collected blood was prepared as previously indicated, and then tested with the kit to determine the level of Trx1. All serum samples were measured twice, and statistical analyses were conducted using ROC analysis, one-way ANOVA, and unpaired t-tests. Results: Clinical sensitivity for BC detection was analyzed using the Trx1 levels of the 254 subjects who underwent both mammography and breast ultrasound. The respective sensitivities of mammography, breast ultrasound, and the DxMe® BC Kit were 72.83%, 92.91%, and 96.46%. With combined analysis of mammography, breast ultrasound, and Trx1, the sensitivity increased to 98.43% for mammography + breast ultrasound, and 98.82% for mammography + Trx1. When breast ultrasound + Trx1 was considered, the sensitivity rose to 99.61%. Likewise, the sensitivity of mammography + breast ultrasound + Trx1 was also measured at 99.61%. Among the 261 breast cancer patients with available information about breast density, 186 patients (71.3%) had dense breasts. The clinical sensitivity of mammography and Trx1 was specifically analyzed for these dense breast cases. Mammography demonstrated a sensitivity of 64.3%, while the DxMe® BC kit exhibited a sensitivity of 97.2%. When mammography and Trx1 were analyzed in parallel, sensitivity increased to 99.7%. Conclusion: This study demonstrated that the DxMe® BC kit, which quantifies serum Trx1 levels, can enhance the accuracy of conventional image-based diagnostics for breast cancer screening and early detection by more than 25%. This improvement in sensitivity was observed when mammography and breast ultrasound were each used in conjunction with Trx1, with no significant difference noted between these two combinations. Notably, in the case of dense breasts, the Trx1 test improved sensitivity by more than 30% compared to mammography. Given that sensitivity increases when mammography and Trx1 tests are used together, it showed that incorporating the Trx1 test alongside traditional mammography could significantly enhance diagnostic performance in dense breasts up to 35%. This approach has the potential to streamline the breast cancer diagnostic process, reduce time and cost, and improve the reliability of current breast cancer screening and early detection methods, regardless of breast density. Citation Format: Young Kim, Hyemi Ko, Yeri Lee, Keunkoo Shin, Jongam Song, Jeryoung Kim, Kyounghoon Suh, Jinsun Lee. Serum Thioredoxin 1 Enhances Breast Cancer Detection in Mammography and Breast Ultrasound, Including Dense Breasts [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl):Abstract nr PO2-13-12.

Abstract PO1-07-03: An Accurate Breast Cancer Diagnosis Method Using a Multi-Feature Fusion Neural Network on Contrast-Enhanced Spectral Mammography

Abstract Objectives: Our study aims to develop an accurate and comprehensive deep neural network capable of classifying CESM images to aid in the early detection and diagnosis of breast cancer in clinical settings. Methods: We enrolled diagnostic CESM examinations conducted between January 1, 2019 and January 17, 2021. We developed and tested the performance of a multi-feature fusion network for breast lesion classification by combining low-energy (LE) and dual-energy subtracted (DES) images, dual-view, and bilateral information using a large and diverse CESM dataset. We have evaluated the ability of the proposed network to generalize on external datasets and the results were reported using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity. Results: In the study period 1973CESMs were included. Mean age was 53 years ± 12 (standard deviation). In the internal test dataset, the model with CESM (LE +DES) inputs combined not only bilateral information (left and right breasts) but also dualview information (CC and MLO), achieved best diagnosis performance with AUC of 0.96 [95% confidence interval (CI): 0.95–0.97], accuracy of 0.9 [95% confidence interval (CI): 0.88–0.92], sensitivity of 0.84 [95% confidence interval (CI): 0.80–0.88] and specificity of 0.93 [95% confidence interval (CI): 0.91–0.95], while the model with LE inputs only got an AUC of 0.94 [95% (CI): 0.93–0.95], accuracy of 0.88 [95% confidence interval (CI): 0.86–0.90], sensitivity of 0.79 [95% confidence interval (CI): 0.74–0.83] and specificity of 0.93 [95% confidence interval (CI): 0.91–0.95] (external dataset: an AUC of 0.90 [95% (CI): 0.85–0.94], accuracy of 0.84 [95% confidence interval (CI): 0.78–0.89], sensitivity of 0.77 [95% confidence interval (CI): 0.61–0.88] and specificity of 0.87 [95% confidence interval (CI):0.80–0.92]). Conclusion: CESM is a promising technique in breast cancer diagnosis due to its high feasibility and potential. The results demonstrate that left-right breast fusion and dual-view fusion are helpful for accurate diagnosis on CESM images. Specifically, dual-energy subtracted (DES) images generated by CESM improve diagnostic accuracy when compared to low-energy (LE) images alone. Keywords: Contrast-enhanced spectral mammography; Deep neural network; Breast cancer diagnosis; Multi-feature fusion Citation Format: Yipeng Song, Wei Jiang. An Accurate Breast Cancer Diagnosis Method Using a Multi-Feature Fusion Neural Network on Contrast-Enhanced Spectral Mammography [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl):Abstract nr PO1-07-03.

BC-QNet: A quantum-infused ELM model for breast cancer diagnosis

The timely and accurate diagnosis of breast cancer is pivotal for effective treatment, but current automated mammography classification methods have their constraints. In this study, we introduce an innovative hybrid model that marries the power of the Extreme Learning Machine (ELM) with FuNet transfer learning, harnessing the potential of the MIAS dataset. This novel approach leverages an Enhanced Quantum-Genetic Binary Grey Wolf Optimizer (Q-GBGWO) within the ELM framework, elevating its performance. Our contributions are twofold: firstly, we employ a feature fusion strategy to optimize feature extraction, significantly enhancing breast cancer classification accuracy. The proposed methodological motivation stems from optimizing feature extraction for improved breast cancer classification accuracy. The Q-GBGWO optimizes ELM parameters, demonstrating its efficacy within the ELM classifier. This innovation marks a considerable advancement beyond traditional methods. Through comparative evaluations against various optimization techniques, the exceptional performance of our Q-GBGWO-ELM model becomes evident. The classification accuracy of the model is exceptionally high, with rates of 96.54 % for Normal, 97.24 % for Benign, and 98.01 % for Malignant classes. Additionally, the model demonstrates a high sensitivity with rates of 96.02 % for Normal, 96.54 % for Benign, and 97.75 % for Malignant classes, and it exhibits impressive specificity with rates of 96.69 % for Normal, 97.38 % for Benign, and 98.16 % for Malignant classes. These metrics are reflected in its ability to classify three different types of breast cancer accurately. Our approach highlights the innovative integration of image data, deep feature extraction, and optimized ELM classification, marking a transformative step in advancing early breast cancer detection and enhancing patient outcomes.

Deep Learning Paradigms for Breast Cancer Diagnosis: A Comparative Study on Wisconsin Diagnostic Dataset

Breast cancer is a highly common and life-threatening disease that affects people worldwide. Early and accurate diagnosis of breast cancer can enhance patients' prognosis and survival rate. This paper conducts a comparative examination of the Wisconsin Breast Cancer Diagnostic (WBCD) dataset by employing four distinct deep learning models: Feedforward Neural Network (FNN), Convolutional Neural Network (CNN), Long Short-Term Memory (LSTM), and Gated Recurrent Unit (GRU). The collection consists of 569 examples of Fine Needle Aspirate (FNA) photographs of breast cancers, with each case containing thirty parameters that define the features of the cell nuclei. By doing a comparative analysis of the advantages and disadvantages of the models, we will evaluate them based on their accuracy, precision, recall, and F1-score. Based on our research, CNN achieves the best level of accuracy at 98.25%, which is followed by GRU at 97.37%, FNN at 96.49%, and LSTM at 95.61%. It is determined that CNN is the most suitable model for this task and that deep learning models are valuable and encouraging tools for diagnosing breast cancer.

Improving Breast Cancer Diagnosis Accuracy by Particle Swarm Optimization Feature Selection

Breast cancer has been one of the leading causes of death among women in the world. Early detection of this disease can save patient’s lives and reduce mortality. Due to the large number of features involved in the diagnosis of this disease, the breast cancer diagnosis process can be time consuming. To reduce cost and time and improving accuracy of breast cancer diagnosis, this paper propose a feature selection algorithm based on particle swarm optimization (PSO) combined with machine learning methods for selection the most effective features for breast cancer diagnosis among all features. In order to evaluate the efficiency of the proposed feature selection method, it was tested on three most common breast cancer datasets available in the University of California, Irvine (UCI) repository named: Coimbra dataset (CD), Wisconsin Diagnostic Breast Cancer dataset (WDBC) and Wisconsin Prognostic Breast Cancer dataset (WPBC). In the Coimbra dataset with all its 9 features and without PSO feature selection algorithm the highest obtained accuracy was 87% by Support Vector Machine method, while with PSO feature selection algorithm the accuracy reached to 91% and the number of features was reduced from 9 to 4. In the WDBC dataset with all its 30 features and without PSO feature selection algorithm the highest obtained accuracy was 99% by Random Forest method, while with PSO feature selection algorithm the accuracy reached to 100% and the number of features was reduced from 30 to 19. In the WPBC dataset with all its 33 features and without PSO feature selection algorithm the highest obtained accuracy was 94% by Support Vector Machine method, while with PSO feature selection algorithm the accuracy reached to 96% and the number of features was reduced from 33 to 17. The results of this paper indicated that the proposed feature selection algorithm based on PSO algorithm can improve the accuracy of breast cancer diagnosis. While it has selected fewer and more effective features than the total number of features in the original datasets.

290 (PB-106) Poster - Improving the accuracy of breast cancer diagnosis in multi-protein signature markers using artificial intelligence algorithms

290 (PB-106) Poster - Improving the accuracy of breast cancer diagnosis in multi-protein signature markers using artificial intelligence algorithms

Uncertainty-aware deep learning-based CAD system for breast cancer classification using ultrasound and mammography images

ABSTRACT Breast cancer is one of the most common types of cancer in women. Early and accurate diagnosis of breast cancer can increase the treatment chances and decrease the mortality rate. Thus, the development of accurate and reliable Computer-Aided Diagnosis (CAD) systems using breast cancer images is an immediate priority for early diagnosis. Deep learning methods have had a widespread role in CAD systems. In spite of the advantages, most deep learning-based CADs cannot quantify the uncertainty of their predictions. Uncertainty in the predicted results from a CAD system might endanger people’s life in these crucial steps for breast cancer classification. Therefore, in this study, the Monte Carlo Dropout method is utilised as an uncertainty quantification method. Furthermore, differently from most existing studies, we present an uncertainty-aware deep learning model which can classify accurately from different types of images, namely, mammograms and ultrasound. The results show the proposed model achieved the accuracy of 99.95% in mammogram dataset, namely, DDSM and 98.40% and 91.34% in ultrasound datasets, namely, BUSM and BUSI, respectively. Finally, since we found the proposed model shows high uncertainty in misclassifications, we suggested to use the uncertainty values to find appropriate subsets for further inspection to increase the performance.

Modern visualization diagnostic methods of non-invasive breast carcinomas (review of literature)

Relevance. Breast carcinomas (BC) remain one of the most actual problems of modern oncology. According to statistics, the incidence of BC is steadily increasing, making it the most common cancer pathology among women. In this situation, the aspect of diagnosing BC at early, non-invasive stages, is certainly important, which still reduces mortality, increases the possibility of organ-preserving treatment, duration and quality of life of patients.The purpose of study. The purpose of study is to investigate and perform a comparative analysis of imaging techniques for the diagnosis of non-invasive breast carcinomas.Materials and methods. Modern Russian and foreign literature about the diagnosis of non-invasive breast carcinomas was analyzed. Publications not older than 7 years published in specialized medical editions were taken into account Results. Not only main, but also new, promising imaging modalities that are not currently part of routine practice were analyzed. The main imaging patterns in non-invasive breast carcinomas (DCIS, LCIS and Paget's breast cancer), feasibility and prognostic value of certain diagnostic methods in different nosologies of this disease were also discussed.Conclusion. The statistics provided explain the importance of breast carcinomas problem, as well as the relevance of its diagnosis at non-invasive stages. According to the authors, the issue of accurate diagnosis of breast cancer in situ is subject to further discussion and study, but we would like to note that when non-invasive breast carcinoma is suspected and doubtful imaging results are obtained, one should not limit oneself only to routine methods of imaging studies, but expand further diagnostic tactics until accurate results are obtained and a final diagnosis is made.

Empowering breast cancer diagnosis and radiology practice: advances in artificial intelligence for contrast-enhanced mammography.

Artificial intelligence (AI) applications in breast imaging span a wide range of tasks including decision support, risk assessment, patient management, quality assessment, treatment response assessment and image enhancement. However, their integration into the clinical workflow has been slow due to the lack of a consensus on data quality, benchmarked robust implementation, and consensus-based guidelines to ensure standardization and generalization. Contrast-enhanced mammography (CEM) has improved sensitivity and specificity compared to current standards of breast cancer diagnostic imaging i.e., mammography (MG) and/or conventional ultrasound (US), with comparable accuracy to MRI (current diagnostic imaging benchmark), but at a much lower cost and higher throughput. This makes CEM an excellent tool for widespread breast lesion characterization for all women, including underserved and minority women. Underlining the critical need for early detection and accurate diagnosis of breast cancer, this review examines the limitations of conventional approaches and reveals how AI can help overcome them. The Methodical approaches, such as image processing, feature extraction, quantitative analysis, lesion classification, lesion segmentation, integration with clinical data, early detection, and screening support have been carefully analysed in recent studies addressing breast cancer detection and diagnosis. Recent guidelines described by Checklist for Artificial Intelligence in Medical Imaging (CLAIM) to establish a robust framework for rigorous evaluation and surveying has inspired the current review criteria.

Identifying tumor cell-released extracellular vesicles as biomarkers for breast cancer diagnosis by a three-dimensional hydrogel-based electrochemical immunosensor

Tumor cell-released LC3+ extracellular vesicles (LC3+ EVs) participate in immunosuppression during autophagy and contribute to the occurrence and development of breast cancer. In view of the strong association between the LC3+ EVs and breast cancer, developing an effective strategy for the quantitative detection of LC3+ EVs levels with high sensitivity to identify LC3+ EVs as new biomarkers for accurate diagnosis of breast cancer is crucial, but yet not been reported. Herein, an ultrasensitive electrochemical immunosensor is presented for the quantitative determination of LC3+ EVs using a three-dimensional graphene oxide hydrogel-methylene blue composite as a redox probe, showing a low detection limit and a wide linear range. With this immunosensor, the expression levels of LC3+ EVs in various practical sample groups including different cancer cell lines, the peripheral blood of tumor-bearing mice before and after immunotherapy, and the peripheral blood from breast cancer patients with different subtypes and stages were clearly distinguished. This study demonstrated that LC3+ EVs were superior as biomarkers for the accurate diagnosis of breast cancer compared to traditional biomarkers, particularly for cancer subtype discrimination. This work would provide a new noninvasive detection tool for the early diagnosis and prognosis assessment of breast cancer in clinics.

Artificial intelligence in breast imaging: potentials and challenges.

Breast cancer, which is the most common type of malignant tumor among humans, is a leading cause of death in females. Standard treatment strategies, including neoadjuvant chemotherapy, surgery, postoperative chemotherapy, targeted therapy, endocrine therapy, and radiotherapy, are tailored for individual patients. Such personalized therapies have tremendously reduced the threat of breast cancer in females. Furthermore, early imaging screening plays an important role in reducing the treatment cycle and improving breast cancer prognosis. The recent innovative revolution in artificial intelligence (AI) has aided radiologists in the early and accurate diagnosis of breast cancer. In this review, we introduce the necessity of incorporating AI into breast imaging and the applications of AI in mammography, ultrasonography, magnetic resonance imaging, and positron emission tomography/computed tomography based on published articles since 1994. Moreover, the challenges of AI in breast imaging are discussed.

Photon Absorption Remote Sensing Imaging of Breast Needle Core Biopsies Is Diagnostically Equivalent to Gold Standard H&E Histologic Assessment.

Photon absorption remote sensing (PARS) is a new laser-based microscope technique that permits cellular-level resolution of unstained fresh, frozen, and fixed tissues. Our objective was to determine whether PARS could provide an image quality sufficient for the diagnostic assessment of breast cancer needle core biopsies (NCB). We PARS imaged and virtually H&E stained seven independent unstained formalin-fixed paraffin-embedded breast NCB sections. These identical tissue sections were subsequently stained with standard H&E and digitally scanned. Both the 40× PARS and H&E whole-slide images were assessed by seven breast cancer pathologists, masked to the origin of the images. A concordance analysis was performed to quantify the diagnostic performances of standard H&E and PARS virtual H&E. The PARS images were deemed to be of diagnostic quality, and pathologists were unable to distinguish the image origin, above that expected by chance. The diagnostic concordance on cancer vs. benign was high between PARS and conventional H&E (98% agreement) and there was complete agreement for within-PARS images. Similarly, agreement was substantial (kappa > 0.6) for specific cancer subtypes. PARS virtual H&E inter-rater reliability was broadly consistent with the published literature on diagnostic performance of conventional histology NCBs across all tested histologic features. PARS was able to image unstained tissues slides that were diagnostically equivalent to conventional H&E. Due to its ability to non-destructively image fixed and fresh tissues, and the suitability of the PARS output for artificial intelligence assistance in diagnosis, this technology has the potential to improve the speed and accuracy of breast cancer diagnosis.

A novel breast cancer detection system using SDM-WHO-RNN classifier with LS-CED segmentation

Breast cancer (BC) is caused by the abnormal and rapid growth of breast cells. Accurate diagnosis of BC at an early stage could minimize the mortality related to this disease. Because of this, researchers have recently developed an automatic recognition system. However, poor image resolution, lower accuracy for deep tumors, biased nature and incapability to localize a lesion, greater rate of False Positives (FPs), and inefficiency towards the overlapped cells are the restrictions encompassed in the majority of the prevailing techniques. The main motive of this proposed work is for detecting the nuclei and classifying the tumor. Finding the nuclei's location is the main goal of the proposed endeavour. The structure of the cell is measured in relation to the nuclei. Hence, superior accuracy in complexity classification could be attained by this incentive. The input image is preprocessed and the contrast is enhanced. By utilizing Linear Scaling centered Canny Edge Detection (LS-CED), these Contrast-Enhanced Images (CEI) are further segmented into several partitions. The nuclei are sensed by utilizing a Soft Plus-Max Region-centered Fully Convolutional Network (SPM-R-FCN) from the segmented images. Then, as per the size and shape of the tumor, the Tumor Cells (TCs) are gauged and classified by utilizing the adaptive threshold function. After that, the most momentous and needed features are extorted as of the gauged TCs. This Extracted Feature (EF) is inputted into the SDM-WHO-RNN classifier that classifies cancer as benign, malignant, and normal. Simulation results demonstrated that the SDM-WHO-RNN approach acquires perfect outcomes as of the experiment and accomplishes 97.9% accuracy.